Personalized neoantigen-pulsed autologous dendritic cells vaccine as an adjuvant treatment for patients with newly-diagnosed glioblastoma multiforme: A phase I trial. Prospective validation from a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback